2,730
Views
3
CrossRef citations to date
0
Altmetric
Endocrinology

Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 533-542 | Received 03 Dec 2022, Accepted 26 Jan 2023, Published online: 06 Feb 2023

References

  • Yaqoob M, Wang J, Sweeney AT, et al. Trends in avoidable hospitalizations for diabetes: experience of a large clinically integrated health care system. J Healthc Qual. 2019;41(3):125–133.
  • Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–232.
  • Desai D, Mehta D, Mathias P, et al. Health care utilization and burden of diabetic ketoacidosis in the U.S. Over the past decade: a nationwide analysis. Diabetes Care. 2018;41(8):1631–1638.
  • Fazeli Farsani S, Brodovicz K, Soleymanlou N, et al. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open. 2017;7(7):e016587.
  • Haris B, Saraswathi S, Al-Khawaga S, et al. Epidemiology, genetic landscape and classification of childhood diabetes mellitus in the state of Qatar. J Diabetes Investig. 2021;12(12):2141–2148.
  • IDF. IDF MENA members; 2021 [accessed 2022 Oct 27]. Available from: https://idf.org/our-network/regions-members/middle-east-and-north-africa/members/45-qatar.html
  • Ahmann A. Reduction of hospital costs and length of stay by good control of blood glucose levels. Endocrine Pract. 2004;10:53–56.
  • Farooq U, Tarar ZI, Kamal F, et al. Is acid suppression associated with the increased length of stay in diabetic ketoacidosis patients? A nationwide analysis. J Intern Med. 2022;292(1):136–145.
  • Friel KM, McCauley C, O’Kane M, et al. Can Clinical outcomes be improved, and inpatient length of stay reduced for adults with diabetes? A systematic review. Front Clin Diabetes Healthcare. 2022;3.
  • Ilag LL, Kronick S, Ernst RD, et al. Impact of a critical pathway on inpatient management of diabetic ketoacidosis. Diabetes Res Clin Pract. 2003;62(1):23–32.
  • Freire AX, Umpierrez GE, Afessa B, et al. Predictors of intensive care unit and hospital length of stay in diabetic ketoacidosis. J Crit Care. 2002;17(4):207–211.
  • Guisado-Vasco P, Cano-Megías M, Carrasco-de la Fuente M, et al. Clinical features, mortality, hospital admission, and length of stay of a cohort of adult patients with diabetic ketoacidosis attending the emergency room of a tertiary hospital in Spain. Endocrinol Nutr. 2015;62(6):277–284.
  • Nassetta L, Shah N, Campbell C, et al. Factors associated with prolonged inpatient stay in pediatric patients admitted for DKA. USA: SHM Converge 2021; 2021.
  • Bhatt P, Dave M, Amponsah JK, et al. Etiologies, trends, and predictors of 30-day pediatric readmissions after hospitalizations for diabetic ketoacidosis in the United States. Pediatr Diabetes. 2020;21(6):969–978.
  • Cully M, Thompson AD, DePiero AD. Is lactic acidosis predictive of outcomes in pediatric diabetic ketoacidosis? Am J Emerg Med. 2020;38(2):329–332.
  • Goad NT, Bakhru RN, Pirkle JL, et al. Association of hyperchloremia with unfavorable clinical outcomes in adults with diabetic ketoacidosis. J Intensive Care Med. 2020;35(11):1307–1313.
  • Ibrahim A, Bayramoglu B, Hokenek NM, et al. Lactate clearance during the first 2 hours after hospital admission: a useful biomarker for predicting 30-day mortality in patients with diabetic ketoacidosis. Int J Clin Pract. 2021;75:e14204.
  • Li W, Hu Y, Xing X, et al. Platelet-to-lymphocyte ratio and the prognosis of diabetic ketoacidosis. Chin J Emerg Med. 2017;26(6):693–696.
  • Liu WY, Lin SG, Wang LR, et al. Platelet-to-lymphocyte ratio: a novel prognostic factor for prediction of 90-day outcomes in critically ill patients with diabetic ketoacidosis. Medicine. 2016;95(4):e2596.
  • Morgan TJ, Scott PH, Anstey CM, et al. Hyperlactatemia in diabetic ketoacidosis is common and can be prolonged: lactate time-series from 25 intensive care admissions. J Clin Monit Comput. 2020;35(4):757–764.
  • Yazıcı MU, Ayar G, Savas-Erdeve S, et al. Role of ischemia modified albumin serum levels as an oxidative stress marker in children with diabetic ketoacidosis. Comb Chem High Throughput Screen. 2019;22(8):577–581.
  • Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Rubin DJ, Shah AA. Predicting and preventing acute care re-utilization by patients with diabetes. Curr Diab Rep. 2021;21(9):34.
  • Hammersen J, Tittel SR, Warncke K, et al. Previous diabetic ketoacidosis as a risk factor for recurrence in a large prospective contemporary pediatric cohort: results from the DPV initiative. Pediatr Diabetes. 2021;22(3):455–462.
  • Ellis D, Naar-King S, Templin T, et al. Multisystemic therapy for adolescents with poorly controlled type 1 diabetes: reduced diabetic ketoacidosis admissions and related costs over 24 months. Diabetes Care. 2008;31(9):1746–1747.
  • Pylväläinen J, Talala K, Murtola T, et al. Charlson Comorbidity Index based on hospital episode statistics performs adequately in predicting mortality, but its discriminative ability diminishes over time. Clin Epidemiol. 2019;11:923–932.
  • Getie A, Wondmieneh A, Bimerew M, et al. Determinants of diabetes ketoacidosis among diabetes mellitus patients at North Wollo and Waghimra zone public hospitals, Amhara region, Northern Ethiopia. BMC Endocr Disord. 2021;21(1):26.
  • Ng AC, Chow V, Yong AS, et al. Prognostic impact of the Charlson Comorbidity Index on mortality following acute pulmonary embolism. Respiration. 2013;85(5):408–416.
  • Alourfi Z, Homsi H. Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus. Avicenna J Med. 2015;5(1):11–15.
  • Mays JA, Jackson KL, Derby TA, et al. An Evaluation of recurrent diabetic ketoacidosis, fragmentation of care, and mortality across Chicago, Illinois. Diabetes Care. 2016;39(10):1671–1676.
  • Burke SD, Sherr D, Lipman RD. Partnering with diabetes educators to improve patient outcomes. Diabetes Metab Syndr Obes. 2014;7:45–53.
  • Almeda-Valdes P, Palacio Ríofrio J, Zamudio Coronado KW, et al. Factors associated with insulin nonadherence in type 1 diabetes mellitus patients in Mexico. Dubai Diabetes Endocrinol J. 2019;25(3-4):139–147.
  • Huang J, Ding S, Xiong S, et al. Medication adherence and associated factors in patients with type 2 diabetes: a structural equation model. Front Public Health. 2021;9:730845.
  • Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307.
  • Phelan H, Hanas R, Hofer SE, et al. Sick day management in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(7):912–925.